PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
COOP vs. KRYS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Performance

COOP vs. KRYS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Mr. Cooper Group Inc. (COOP) and Krystal Biotech, Inc. (KRYS). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%JuneJulyAugustSeptemberOctoberNovember
16.36%
5.23%
COOP
KRYS

Returns By Period

In the year-to-date period, COOP achieves a 49.09% return, which is significantly higher than KRYS's 43.56% return.


COOP

YTD

49.09%

1M

5.64%

6M

16.36%

1Y

61.82%

5Y (annualized)

49.65%

10Y (annualized)

16.65%

KRYS

YTD

43.56%

1M

-0.49%

6M

5.23%

1Y

75.90%

5Y (annualized)

26.85%

10Y (annualized)

N/A

Fundamentals


COOPKRYS
Market Cap$6.21B$5.12B
EPS$7.78$1.78
PE Ratio12.4899.92
Total Revenue (TTM)$2.12B$241.52M
Gross Profit (TTM)$933.00M$220.04M
EBITDA (TTM)$736.00M$63.99M

Key characteristics


COOPKRYS
Sharpe Ratio2.371.22
Sortino Ratio3.242.54
Omega Ratio1.391.29
Calmar Ratio5.203.05
Martin Ratio15.826.88
Ulcer Index3.99%10.17%
Daily Std Dev26.57%57.49%
Max Drawdown-87.08%-53.42%
Current Drawdown-4.28%-16.64%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Correlation

-0.50.00.51.00.2

The correlation between COOP and KRYS is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Risk-Adjusted Performance

COOP vs. KRYS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Mr. Cooper Group Inc. (COOP) and Krystal Biotech, Inc. (KRYS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for COOP, currently valued at 2.37, compared to the broader market-4.00-2.000.002.004.002.371.22
The chart of Sortino ratio for COOP, currently valued at 3.24, compared to the broader market-4.00-2.000.002.004.003.242.54
The chart of Omega ratio for COOP, currently valued at 1.39, compared to the broader market0.501.001.502.001.391.29
The chart of Calmar ratio for COOP, currently valued at 5.20, compared to the broader market0.002.004.006.005.203.05
The chart of Martin ratio for COOP, currently valued at 15.82, compared to the broader market-10.000.0010.0020.0030.0015.826.88
COOP
KRYS

The current COOP Sharpe Ratio is 2.37, which is higher than the KRYS Sharpe Ratio of 1.22. The chart below compares the historical Sharpe Ratios of COOP and KRYS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Rolling 12-month Sharpe Ratio0.001.002.003.004.00JuneJulyAugustSeptemberOctoberNovember
2.37
1.22
COOP
KRYS

Dividends

COOP vs. KRYS - Dividend Comparison

Neither COOP nor KRYS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

COOP vs. KRYS - Drawdown Comparison

The maximum COOP drawdown since its inception was -87.08%, which is greater than KRYS's maximum drawdown of -53.42%. Use the drawdown chart below to compare losses from any high point for COOP and KRYS. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-4.28%
-16.64%
COOP
KRYS

Volatility

COOP vs. KRYS - Volatility Comparison

The current volatility for Mr. Cooper Group Inc. (COOP) is 9.88%, while Krystal Biotech, Inc. (KRYS) has a volatility of 13.41%. This indicates that COOP experiences smaller price fluctuations and is considered to be less risky than KRYS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%JuneJulyAugustSeptemberOctoberNovember
9.88%
13.41%
COOP
KRYS

Financials

COOP vs. KRYS - Financials Comparison

This section allows you to compare key financial metrics between Mr. Cooper Group Inc. and Krystal Biotech, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items